Latest in News & Research

Is Deucravacitinib Better Than Placebo, Apremilast for Scalp Psoriasis?

Deucravacitinib more efficacious for improving moderate-to-severe scalp psoriasis, and is well tolerated

By Dermsquared Editorial Team | | December 27, 2023

Study Looks at Incidence of Melanoma Among Indigenous Americans

Incidence rates higher among men than women and for those aged 55 years or older versus age 15 to 39 years

By Dermsquared Editorial Team | | December 27, 2023

One in Five New Dermatology Drugs Were First in Class Over the Past Decade

Furthermore, nearly four in 10 new dermatologic drug approvals were deemed clinically useful

By Lori Solomon (HealthDay News) | | December 22, 2023

Launch Alert: Adbry Approval for Pediatric AD

Expanded approval for pediatric patients alters the landscape for moderate-to-severe atopic dermatitis care

By Dermsquared Editorial Team | | December 22, 2023

Risk for Vitiligo Increased for Transplant Recipients

Increased risk seen for those receiving allogeneic grafts and autologous grafts, as well as those with and without comorbid GVHD

By Elana Gotkine (HealthDay News) | | December 21, 2023

Osteoporosis Risk Increased With Long-Term Topical Corticosteroid Exposure

Dose-response relationships identified between long-term exposure to TCSs and osteoporosis and major osteoporotic fracture

By Elana Gotkine (HealthDay News) | | December 20, 2023

Can an Ensemble-Based AI Model Detect Cutaneous Melanoma?

BEDLM gave the highest accuracy in the independent set test compared with the self-consistency, tenfold cross-validation tests

By Dermsquared Editorial Team | | December 20, 2023

Topical PDE4 Inhibitor Well Tolerated, Efficacious in Eczema, Plaque Psoriasis

Significantly greater improvements seen for the PF-07038124 groups compared with vehicle groups at six weeks

By Dermsquared Editorial Team | | December 20, 2023

LAUNCH ALERT: FDA Approves Roflumilast Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis

Breakthrough approval revolutionizes seborrheic dermatitis treatment

By Dermsquared Editorial Team | | December 20, 2023

Risk for Skin Cancer Increased for Patients With Lower Extremity Lymphedema

Lymphedematous extremity 2.65 times as likely as the nonlymphedematous extremity to have skin cancer

By Elana Gotkine (HealthDay News) | | December 18, 2023

Efficacy Shown for New Melanoma Therapeutic Vaccine

Patients who received the vaccine plus Keytruda were 49 percent less likely to die or have their cancer return after three years

By Physician’s Briefing Staff (HealthDay News) | | December 15, 2023

Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA® (tapinarof) Cream, 1% for the Treatment of Plaque Psoriasis in the Head and Neck Region in Adults

New data highlights the versatility of VTAMA cream, an efficacious, safe and well-tolerated, nonsteroidal treatment option for plaque psoriasis in all affected areas of...

By Dermsquared Editorial Team | | December 15, 2023

Blacks More Likely to Have Disseminated Manifestations of Lyme Disease

Black patients have significantly longer median time to appropriate antibiotic treatment than Whites

By Elana Gotkine (HealthDay News) | | December 14, 2023

Is Phototherapy Linked to Increased Risk for Skin Cancer?

No significant difference seen between tumor-based age-standardized incidence rates of skin cancer compared with general population

By Dermsquared Editorial Team | | December 13, 2023

Mohs Linked to Low Recurrence in Nail Unit Squamous Cell Carcinoma

Kaplan-Meier localized recurrence rate at one and five years 1.00 and 2.12 percent in cohort of MMS-treated patients

By Dermsquared Editorial Team | | December 13, 2023

Barbers Can Partner With Dermatologists to Augment Pseudofolliculitis Barbae Care

Educational intervention successfully increased barbers’ knowledge of causes, prevention, and treatment

By Lori Solomon (HealthDay News) | | December 11, 2023

Stigmatizing Attitudes Identified Toward Individuals With Acne

Participants reported less comfort being friends with, hiring, having physical contact, dating someone with severe acne

By Elana Gotkine (HealthDay News) | | December 07, 2023

Can an Elastic-Scattering Spectroscopy Device Aid Skin Cancer Detection?

Device has high sensitivity for detection of melanoma, basal cell carcinoma, squamous cell carcinoma

By Dermsquared Editorial Team | | December 06, 2023

Bimekizumab Beneficial for Treating Palmoplantar Pustulosis

Case series also shows improvement for patients with palmoplantar plaque psoriasis with pustules, SAPHO syndrome

By Dermsquared Editorial Team | | December 06, 2023

Career Goals and How They Impact Your Dermatology Job Search

In the world of dermatology, the pursuit of a fulfilling career often begins with a clear set of goals. Whether you’re an experienced practitioner...

By myDermRecruiter | | December 04, 2023

No Increased Suicide Risk Observed for Isotretinoin Users

Likelihood of attempting suicide lower at two, three, and four years following treatment in isotretinoin users

By Elana Gotkine (HealthDay News) | | December 04, 2023

Ichthyosis Tied to Increased Risk for Depression, Anxiety

Authors say results suggest the need for increased screening in patients with ichthyosis

By Lori Solomon (HealthDay News) | | December 01, 2023

AI Accurate in Diagnosing Suspicious Skin Lesions

AI may be less accurate than clinicians in usage for management decisions

By Lori Solomon (HealthDay News) | | November 29, 2023

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026